Cognitive Performance and Plasma Levels of Homocysteine, Vitamin B12, Folate and Lipids in Patients with Alzheimer Disease
Open accessThe DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Abstract
Background: Conflicting results have been reported on the association of plasma total homocysteine (tHcy) and cholesterol levels in Alzheimer disease (AD). The objective of this study was to determine the relationship between cognitive performance and plasma levels of tHcy and its biological determinants folate and vitamin B 12, and lipids in clinically diagnosed AD patients. Methods: A cross-sectional database review was performed on two separate groups of patients (n = 191). Mini-Mental State Exam (MMSE) scores, plasma levels of tHcy, vitamin B 12, folate, cholesterol, and triglycerides were analyzed. Results: The MMSE scores were inversely correlated with age, plasma levels of tHcy and LDL cholesterol. However, only the inverse relationship between MMSE scores and LDL cholesterol levels persisted after adjustment for age, sex, and status of statin treatment. Plasma tHcy levels increased significantly with age and were inversely related to vitamin B 12 and folate levels, which modified the relationship between MMSE scores and plasma tHcy levels. Conclusions: The plasma tHcy levels appeared to relate more to aging than to cognition. Cognitive performance was inversely associated with plasma LDL cholesterol levels in AD patients. Our findings provide further evidence that high LDL cholesterol levels may play a role in the pathogenesis of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An antagonistic interaction of folate and Vitamin B-12 with Hcy’s effect on cognition was noted in other studies [224,296,297].”
From Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis (2014) · cites this paper as [296]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · cited 1×
“Patients with MCI were excluded from this analysis. Only patients with a diagnosis of probable or possible AD according to NINCDS-ADRDA criteria [”
MethodHirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,038
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J. M., & Wouters, E. J. M. (2016) · Gerontology · doi:10.1159/000430949 · Cited by 19,690
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. (2015) · Gerontology · doi:10.1159/000362720 · Cited by 18,909
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · cited 1×
“All of these mutations cause increased production of highly amyloidogenic Aβ peptides that are deposited in the senile plaques.Increasing evidence suggests that cardiovascular risk factors may play important roles in the development of AD. The apolipoprotein (apo) E4 allele, associated with hypercholesterolemia and co…”
BackgroundMild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Gauthier, S., Reisberg, B., Zaudig, M., Petersen, R. C., Ritchie, K., Broich, K., Belleville, S., Brodaty, H., Bennett, D., Chertkow, H., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 3,850
Research works printed but not linked: 2
- 10.1001%2fjama.274.13.1049 · doi:10.1001/jama.274.13.1049 · Paper page
- 10.1001%2fjama.270.22.2693 · DOI
Cited by
Beydoun, M. A., Beydoun, H. A., Gamaldo, A. A., Teel, A., Zonderman, A. B., & Wang, Y. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-643 · Cited by 671
“An antagonistic interaction of folate and Vitamin B-12 with Hcy’s effect on cognition was noted in other studies [224,296,297].”
ResultReitz, C., Tang, M.-X., Schupf, N., Manly, J. J., Mayeux, R., & Luchsinger, J. A. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.297 · Cited by 205
Wang, Z., Zhu, W., Xing, Y., Jia, J., & Tang, Y. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuab057 · Cited by 144
Li, H., Kang, T., Qi, B., Kong, L., Jiao, Y., Cao, Y., Zhang, J., & Yang, J. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.12.020 · Cited by 129
Homocysteine and cognition: A systematic review of 111 studies
Setién‐Suero, E., Suárez‐Pinilla, M., Suárez‐Pinilla, P., Crespo‐Facorro, B., & Ayesa‐Arriola, R. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.08.014 · Cited by 101
“Four of them, showed an inverse association between the plasma Hcy levels and the MMSE scores (42-45).”
BackgroundReiman, E. M., Chen, K., Langbaum, J. B. S., Lee, W., Reschke, C., Bandy, D., Alexander, G. E., & Caselli, R. J. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2009.07.025 · Cited by 70
“…duration of treatment and age in which treatment was started, particularly because findings from some studies suggest that statin use may be most effective at reducing incident AD in persons younger than 80 years of age (Cramer et al., 2008; Li et al., 2006, 2007, 2008; Rockwood et al., 2002).”
BackgroundHomocysteine, Cognitive Functions, and Degenerative Dementias: State of the Art
Luzzi, S., Cherubini, V., Falsetti, L., Viticchi, G., Silvestrini, M., & Toraldo, A. (2022) · Biomedicines · doi:10.3390/biomedicines10112741 · Cited by 70
Cankurtaran, M., Yesil, Y., Kuyumcu, M. E., Oztürk, Z. A., Yavuz, B. B., Halil, M., Ulger, Z., Cankurtaran, E. S., & Arıoğul, S. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2012-121630 · Cited by 63
Cobalamin deficiency, hyperhomocysteinemia, and dementia
Werder (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s6564 · Cited by 65
Blom, K., Emmelot‐Vonk, M. H., & Koek, H. L. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.06.011 · Cited by 59
Politis, A. M., Olgiati, P., Malitas, P. N., Albani, D., Signorini, A., Polito, L., Mauro, S. D., Zisaki, A., Piperi, C., Stamouli, E., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1252 · Cited by 55
“In a cross-sectional analysis of patients with clinically diagnosed AD, MMSE scores were inversely correlated with plasma homocysteine but not after adjustment for age [35], suggesting that homocysteine levels might relate more to ageing than to cognitive functioning.”
BackgroundXuan, K., Zhao, T., Qu, G., Liu, H., Chen, X., & Sun, Y. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04243-6 · Cited by 50
Zhao, B., Shang, S., Li, P., Chen, C., Dang, L., Jiang, Y., Wang, J., Huo, K., Deng, M., Wang, J., et al. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-018-0956-5 · Cited by 47
Ahmed, H. H. (2010) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2010.11.012 · Cited by 45
Inflammation as a Possible Link Between Dyslipidemia and Alzheimer’s Disease
Oliveira, B. C. D. L., Bellozi, P. M. Q., Reis, H. J., & de Oliveira, A. C. P. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.02.012 · Cited by 43
Lesser, G. T., Beeri, M. S., Schmeidler, J., Purohit, D. P., & Haroutunian, V. (2011) · Current Alzheimer Research · doi:10.2174/156720511795563755 · Cited by 39
Serum Folate, Homocysteine, Brain Atrophy, and Auto-CM System: The Treviso Dementia (TREDEM) Study
Gallucci, M., Zanardo, A., Bendini, M., Paola, F. D., Boldrini, P., & Grossi, E. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130956 · Cited by 36
“of homocysteine in the blood are related to dementia, Alzheimer’s disease (AD), and poor cognitive function in older adults [1–8].”
BackgroundThe Progression of Alzheimer’s Disease: Are Fast Decliners Really Fast? A Four-Year Follow-Up
Barocco, F., Spallazzi, M., Concari, L., Gardini, S., Pelosi, A., & Caffarra, P. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161264 · Cited by 35
“Helzner et al., 2009; Li et al., 2008 > (only LDL) [4, 46] Diabetes Mellitus Dominguez et al., 2012; Ravona-Springer et al., 2010; Sanz et al., 2009; Musicco et al., 2009; Mielke et al., 2007 < [6–9, 48] Helzner et al., 2009; Li et al., 2010 > [4, 45] Abellan van Kan et al., 2009; Sakurai et al.,…”
BackgroundLi, H., Song, J., Zhang, J., Wang, T., Yan, Y., Tao, Z., Li, S., Zhang, H., Kang, T., & Yang, J. (2016) · Phytotherapy Research · doi:10.1002/ptr.5747 · Cited by 32
“, 2013); therefore, combining D-gal with Al has become a useful animal model that has been widely used to study potential treatments for AD (Sun et al., 2009; Honig et al., 2003; van Oijen et al., 2005; Xiao et al., 2011;Luo et al., 2009;Peng et al., 2015;Yang et al., 2014; Yang et al., 2013; Li et al., 2008; Zhang et…”
MethodRaszewski, G., Chwedorowicz, R., Chwedorowicz, A., & Gustaw‐Rothenberg, K. (2015) · Annals of Agricultural and Environmental Medicine · doi:10.5604/12321966.1196878 · Cited by 30
“Although some studies found no association between plasma tHcy levels and cognitive impairment in patients with AD [16], in the presented study, the mean serum tHcy concentrations for AD and n-AD patients were elevated in comparison to upper reference limits for tHcy (20 μmol/l) in patients aged >65 years, and in comp…”
BackgroundResultBrown, L. A., Riby, L. M., & Reay, J. L. (2009) · Experimental Aging Research · doi:10.1080/03610730903417960 · Cited by 26
“( 2009 ) found no independent association between plasma total homocysteine and MMSE performance in AD patients but, similarly, for the vast majority of participants, homocysteine concentration fell within the normal range.”
BackgroundBlasko, I., Defrancesco, M., Oberacher, H., Loacker, L., Kemmler, G., Marksteiner, J., & Humpel, C. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111264 · Cited by 25
“While these data are not new, it shows that in our hands we can reproduce previous data (de Wilde et al., 2017; Li et al., 2008), which also supports the correct classification of our patients.”
Ahmed, H. H., Shousha, W. G., HUSSIEN, R. M., & Farrag, A. R. H. (2011) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-0907-136 · Cited by 21
Agarwal, R., Chhillar, N., Kushwaha, S. S., Singh, N., & Tripathi, C. (2010) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.74193 · Cited by 19
“However, Li et al.[16] showed that vitamin B12 and folate levels were not related to cognitive function and also found negative correlation between plasma vitamin B12 levels and MMSE score in AD patients.”
BackgroundInfluentialWu, M., Lu, Y., Huang, C., Lin, P., Chen, N.-C., Lui, C., Chang, W., Lee, C., Chang, Y., Chen, S.-F., et al. (2015) · Medicine · doi:10.1097/md.0000000000001192 · Cited by 15
Nilsson, K. H., Gustafson, L., & Hultberg, B. L. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000319535 · Cited by 15
Homocysteine in Alzheimer's disease: role of dietary folate, vitamin B6 and B12
Nilforooshan, R., Broadbent, D., Weaving, G., Gurton, J., Moore, V., Houston, L. A., & Tabet, N. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2666 · Cited by 11
“It has been suspected that the plasma Hcy levels appear to relate more to aging than to cognition (Li et al., 2008).”
BackgroundRogne, S., Vangberg, T. R., Eldevik, P., Wikran, G., Mathiesen, E. B., & Schirmer, H. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000350408 · Cited by 11
Raszewski, G., Loroch, M., Owoc, A., Łukawski, K., Filip, R., & Bojar, I. (2015) · Archives of Women s Mental Health · doi:10.1007/s00737-015-0518-z · Cited by 10
“Most, but not all (Li et al. 2008), works have demonstrated that estrogen therapy reduces plasma tHcy concentrations (Clarke 2008).”
BackgroundNguyen, V. P., Collins, A. E., Hickey, J. P., Pfeifer, J. A., & Kalisch, B. E. (2023) · Brain Sciences · doi:10.3390/brainsci13010153 · Cited by 9
“Hcy has been implicated in increased oxidative stress and neurodegeneration, and an increase in the levels of Hcy in blood is a marker for vitamin B12 deficiency [10,14].”
BackgroundResultInfluentialXiang, Y., Song, F., Jiang, L., Liu, Z., & Tu, Y. (2022) · Journal of AOAC International · doi:10.1093/jaoacint/qsac033 · Cited by 9
Correlation Between Dietary Nutrition and Glymphatic System Activity in Healthy Participants
Ota, M., Nemoto, K., Hori, H., Ishida, I., Sato, S., Asada, T., Kunugi, H., & Arai, T. (2025) · Cureus · doi:10.7759/cureus.77860 · Cited by 8
Correlation of metal ions with specific brain region volumes in neurodegenerative diseases
Melek, İ., Kuş, B., Kaptan, Z., & Petekkaya, E. (2023) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.55730/1300-0144.5714 · Cited by 8
“Alzheimer’s disease (AD) is a progressive neurodegenerative disease with high prevalence [1–3].”
BackgroundAllam, M., Fahmy, E. M., Sharaf, S. A. E.-A., Amer, H. M. A., Abokrysha, N. T., & ELSawy, E. E. T. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.06.023 · Cited by 8
“[29] who reported Plasma tHcy levels significantly increased with age and were inversely related to vitamin B12 and folate levels.”
Plasma homocysteine and longitudinal change in cognitive function among urban adults
Beydoun, M. A., Beydoun, H. A., Georgescu, M. F., Vieytes, C. A. M., Kuczmarski, M. F., Hooten, N. N., Evans, M. K., & Zonderman, A. B. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.08.010 · Cited by 6
A Review on Current Strategies and Future Perspective in Respect to Alzheimer’s Disease Treatment
Bais, S., Kumari, R., & Prashar, Y. (2015) · Current Research in Neuroscience · doi:10.3923/crn.2016.1.15 · Cited by 6
Júnior, O. V. R., Silveira, J. S., Gusso, D., Prauchner, G. R. K., Deniz, B. F., de Almeida, W., Pereira, L. O., & Wyse, Â. T. D. S. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.111260 · Cited by 5
Mehl‐Madrona, L., & Mainguy, B. (2017) · The Permanente Journal · doi:10.7812/tpp/16-027 · Cited by 5
Association between vascular measures and cognitive function in type 2 diabetes
Low, S. K., Ng, T. P., Lim, C. L., Wang, J., Moh, A. M. C., Ang, S. F., Goh, K. S., Ang, K., Tang, W. E., Kwan, P. Y., et al. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107724 · Cited by 5
Nutrition in the Prevention and Treatment of Cognitive Decline
Giles, G. E., D’Anci, K. E., & Kanarek, R. B. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1929-1_8 · Cited by 3
“It is not clear, however, whether the relationship between APOE ε 4 status, B vitamin status, and cognitive performance is directly related to brain function, or if the relationship is more indirectly a result of increased risk for cardiovascular disease [ 60 , 61 ].”
BackgroundKim, S.-H., & Kim, J.-S. (2012) · Journal of the Korean Society of Physical Medicine · doi:10.13066/kspm.2012.7.2.149 · Cited by 2
Role of Homocysteine in Diseases: A Review
Binabaj, M. M., Joshaghani, H., & Nejabat, M. (2016) · Medical Laboratory Journal · doi:10.18869/acadpub.mlj.10.5.1 · Cited by 2
Beydoun, M. A., Tajuddin, S. M., Shaked, D., Beydoun, H. A., Evans, M. K., & Zonderman, A. B. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.05.013 · Cited by 2
Zhao, C., Abbott, K. A., Udeh‐Momoh, C. T., Price, G. J., Robinson, O., Kang, S., & de Jager, C. A. (2025) · Nutrients · doi:10.3390/nu17091407 · Cited by 1
“…HDL cholesterol is able to reduce oxidative stress and inflammation in blood vessels and to prevent neurodegeneration caused by elevated Hcy levels, which works synergistically with the effects of B vitamins in the methionine cycle, potentially leading to a change in cognitive outcomes [49,50].”
Epidémiologie des démences en Afrique centrale : Mortalité et incidence en population congolaise
Samba, H. (2016) · theses.fr (ABES) · doi:10.70675/b000c9e3z9838z44e7zacb9ze38ac4f7c4ac · Cited by 1
Lorette, A. (2012)
Current awareness in geriatric psychiatry
(2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2115
Vascular risk factors, brain changes and cognitive functioning in mid and late life
Blom, K. (2021) · Utrecht University Repository (Utrecht University) · doi:10.33540/1074
Wu, C., Wu, C., Yin, X., & Zhong, C. (2026) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s553269
Metadata
- Authors
- Li, L., Cao, D., Desmond, R., Rahman, A., Lah, J. J., Levey, A. I., & Zamrini, E.
- Affiliations
- University of Alabama at Birmingham (US)
- Emory University (US)
- Venue
- Dementia and Geriatric Cognitive Disorders
- Publisher
- S. Karger AG
- Published
- 2008
- Volume
- 26
- Issue
- 4
- Pages
- 384-390
- ISSN
- 1420-8008 (ISSN-L)
- 1421-9824
- PMC
- PMC2679366
- OpenAlex
- W1998386491
- Cited by
- 45
- References
- 60
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 2 · 2013: 5 · 2012: 2
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Dementia and Geriatric Cognitive Disorders (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association
- National Institutes of Health
- National Institute on Aging (AG 031846, R21AG025949, R01AG031846, AG 16582, P50AG016582, AG025949, P50AG025688)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Alzheimer's disease, homocysteine, vitamin B12, folic acid, LDL cholesterol, triglycerides, cognitive performance, Mini-Mental State Examination, aging, statin therapy, lipid metabolism
- MeSH terms
- Aged, Alzheimer Disease, Cognition, Cross-Sectional Studies, Female, Folic Acid, Homocysteine, Humans, Lipids, Cholesterol, HDL, Cholesterol, LDL, Male, Psychomotor Performance, Sex Characteristics, Triglycerides, Vitamin B 12, Databases, Factual
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.